HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen Rysgaard Selected Research

SPD 502

9/2013A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen Rysgaard Research Topics

Disease

1Status Epilepticus (Complex Partial Status Epilepticus)
09/2013

Drug/Important Bio-Agent (IBA)

1SPD 502IBA
09/2013
1Pharmaceutical PreparationsIBA
09/2013